US FDA moves to improve transparency in dealings with industry
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has created a new web page to help pharmaceutical, medtech and other companies save time and resources in their interactions with the agency1,2. The FDA has also issued a report containing 19 action items and five draft proposals to improve transparency in its dealings with the industry3.